Takashi Okai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Takashi Okai has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Atsushi Yanaihara
Denentoshi Ladies Clinic Reproductive Center, 2-3-10-5F Aoba-ku, Yokohama-shi, Kanagawa 227-0062, Japan
4 shared publications - Kiyotake Ichizuka
Department of Obstetrics and Gynecology Showa University Northern Yokohama Hospital Yokohama Kanagawa Japan
3 shared publications Hiroshi Saito
Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo
2 shared publicationsKeiko Koide
2 shared publications- Ryu Matsuoka
Department of Obstetrics and Gynecology, Showa University School of Medicine
2 shared publications - Shinji Iwasaki
Department of Obstetrics and Gynecology Showa University School of Medicine 1-5-8, Hatanodai, Shinagawa-ku, Tokyo, Japan
2 shared publications
Latest Publications
- Open Access
- 8 January 2017
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 14 (1) , 52
Maternal Exposure to Pyrethroid Insecticides during Pregnancy and Infant Development at 18 Months of Age
The possible association between maternal exposure to pyrethroid insecticides (PYRs) during pregnancy and infant development was explored. Levels of exposure to PYRs was assessed by metabolite (3-phenoybenzoic acid, 3-PBA) concentration in maternal spot urine sampled in the first trimester of index pregnancy, and infant development was assessed at 18 months of age using the Kinder Infants Development Scale (KIDS), which is based on a questionnaire to the caretaker. The relationship between KIDS score and maternal urinary 3-PBA levels was examined by a stepwise multiple regression analysis using biological attributes of the mother and infant, breast feeding, and nursing environment as covariates. The analysis extracted 3-PBA and the nursing environment as significant to explain the KIDS score at 18 months of age with positive partial regression coefficients. Inclusion of fish consumption frequency of the mother during pregnancy as an independent variable resulted in the selection of fish consumption as significant, while the two variables were marginally insignificant but still with a positive coefficient with the KIDS score. The result suggested a positive effect of maternal PYR exposure on infant development, the reason for which is not clear, but an unknown confounding factor is suspected.
- 8 January 2017
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 14 (1) , 52
Open AccessMaternal Exposure to Pyrethroid Insecticides during Pregnancy and Infant Development at 18 Months of Age
The possible association between maternal exposure to pyrethroid insecticides (PYRs) during pregnancy and infant development was explored. Levels of exposure to PYRs was assessed by metabolite (3-phenoybenzoic acid, 3-PBA) concentration in maternal spot urine sampled in the first trimester of index pregnancy, and infant development was assessed at 18 months of age using the Kinder Infants Development Scale (KIDS), which is based on a questionnaire to the caretaker. The relationship between KIDS score and maternal urinary 3-PBA levels was examined by a stepwise multiple regression analysis using biological attributes of the mother and infant, breast feeding, and nursing environment as covariates. The analysis extracted 3-PBA and the nursing environment as significant to explain the KIDS score at 18 months of age with positive partial regression coefficients. Inclusion of fish consumption frequency of the mother during pregnancy as an independent variable resulted in the selection of fish consumption as significant, while the two variables were marginally insignificant but still with a positive coefficient with the KIDS score. The result suggested a positive effect of maternal PYR exposure on infant development, the reason for which is not clear, but an unknown confounding factor is suspected.
- 1 October 2011
- Published by Japanese Society of Mammalian Ova Research in Journal of Mammalian Ova Research
- Vol. 28 (3) , 103-109
Role of Epigenetics in the Placenta: Alterations in DNA Promoter Mmethylation and Limprinted Genes
Many researchers are focusing on epigenetic regulation in the placenta. Because the proper development and function of the placenta are crucial for the normal healthy growth and survival of the developing fetus, the study of epigenetic alterations is providing critical insights into the biology of fetal development and the pathogenesis of complications in pregnancy. One epigenetic alteration is genomic imprinting. Alleles from both the father and mother are necessary for normal human and placental development. For example, the paternally expressed IGF2 gene and maternally expressed H19 gene are located in 11p15.5 and they are coordinately regulated by differentially methylated regions (DMRs). The main phenotype of Silver-Russell syndrome is severe fetal growth retardation (FGR) that is caused by a reduction in IGF2 transcription as a result of a loss of methylation at the H19 DMR. Hypermethylation at the H19 DMR is found in 30% of cases of Beckwith-Wiedemann syndrome and the overgrowth phenotype. The other main mechanism is a promoter DNA methylation. Hypomethylation of a promoter of the SERPINA3 gene in the placenta is associated with FGR and preeclampsia. These clues to the epigenetic phenomena involved in the processes of human development and disease in pregnancy have been found in recent years.
- 1 October 2011
- Published by Japanese Society of Mammalian Ova Research in Journal of Mammalian Ova Research
- Vol. 28 (3) , 103-109
Role of Epigenetics in the Placenta: Alterations in DNA Promoter Mmethylation and Limprinted Genes
Many researchers are focusing on epigenetic regulation in the placenta. Because the proper development and function of the placenta are crucial for the normal healthy growth and survival of the developing fetus, the study of epigenetic alterations is providing critical insights into the biology of fetal development and the pathogenesis of complications in pregnancy. One epigenetic alteration is genomic imprinting. Alleles from both the father and mother are necessary for normal human and placental development. For example, the paternally expressed IGF2 gene and maternally expressed H19 gene are located in 11p15.5 and they are coordinately regulated by differentially methylated regions (DMRs). The main phenotype of Silver-Russell syndrome is severe fetal growth retardation (FGR) that is caused by a reduction in IGF2 transcription as a result of a loss of methylation at the H19 DMR. Hypermethylation at the H19 DMR is found in 30% of cases of Beckwith-Wiedemann syndrome and the overgrowth phenotype. The other main mechanism is a promoter DNA methylation. Hypomethylation of a promoter of the SERPINA3 gene in the placenta is associated with FGR and preeclampsia. These clues to the epigenetic phenomena involved in the processes of human development and disease in pregnancy have been found in recent years.
- Open Access
- 11 April 2005
- Published by Springer Nature in Journal of Experimental & Clinical Assisted Reproduction
- Vol. 2 (1) , 6
Localization and gene expression of steroid sulfatase by RT-PCR in cumulus cells and relationship to serum FSH levels observed during in vitro fertilization
Background: The purpose of this study was to localize the expression of steroid sulfatase (STS) in cumulus cells and to determine the relationship between STS mRNA expression and the serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol and progesterone. Methods: The subject group included 49 women (29 to 44 years old) for whom in vitro fertilization treatment was indicated. All subjects gave informed consent. One hundred fourteen samples of cumulus-oocyte complex (COC) were obtained under microscopic observation. Part of the COC was stained by STS antibody. RNA was extracted by phenol-chloroform method and real-time PCR was performed. Serum of each patient was collected and was measured by ELISA. Results: Some of the cumulus samples were stained by STS antibody. The expression of STS mRNA in all samples was confirmed by quantitative RT-PCR. Although there was no significant correlation between the level of STS mRNA and the serum levels of estradiol, progesterone and LH, there was a statistically significant negative correlation between the level of STS mRNA expression and the serum level of FSH (n = 105, p = 0.018, r = -0.22). Conclusion: These results have demonstrated for the first time the expression of STS in cumulus cells by immunohistological stainings and real-time RT-PCR. STS expression in cumulus cells may be related to the control of the local steroidal environment in the oocyte. Serum FSH may control STS mRNA expression from the results of RT-PCR, although the correlation was low.
- 11 April 2005
- Published by Springer Nature in Journal of Experimental & Clinical Assisted Reproduction
- Vol. 2 (1) , 6
Open AccessLocalization and gene expression of steroid sulfatase by RT-PCR in cumulus cells and relationship to serum FSH levels observed during in vitro fertilization
Background: The purpose of this study was to localize the expression of steroid sulfatase (STS) in cumulus cells and to determine the relationship between STS mRNA expression and the serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol and progesterone. Methods: The subject group included 49 women (29 to 44 years old) for whom in vitro fertilization treatment was indicated. All subjects gave informed consent. One hundred fourteen samples of cumulus-oocyte complex (COC) were obtained under microscopic observation. Part of the COC was stained by STS antibody. RNA was extracted by phenol-chloroform method and real-time PCR was performed. Serum of each patient was collected and was measured by ELISA. Results: Some of the cumulus samples were stained by STS antibody. The expression of STS mRNA in all samples was confirmed by quantitative RT-PCR. Although there was no significant correlation between the level of STS mRNA and the serum levels of estradiol, progesterone and LH, there was a statistically significant negative correlation between the level of STS mRNA expression and the serum level of FSH (n = 105, p = 0.018, r = -0.22). Conclusion: These results have demonstrated for the first time the expression of STS in cumulus cells by immunohistological stainings and real-time RT-PCR. STS expression in cumulus cells may be related to the control of the local steroidal environment in the oocyte. Serum FSH may control STS mRNA expression from the results of RT-PCR, although the correlation was low.
- Open Access
- 1 January 2004
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 2 (1) , 66
Comparison in gene expression of secretory human endometrium using laser microdissection
- 1 January 2004
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 2 (1) , 66
Open AccessComparison in gene expression of secretory human endometrium using laser microdissection
- 1 February 2002
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 28 (1) , 35
Immunohistochemical Study of Steroid Sulfatase in Minimal Deviation Adenocarcinoma of the Uterine Cervix
- 1 February 2002
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 28 (1) , 35
Immunohistochemical Study of Steroid Sulfatase in Minimal Deviation Adenocarcinoma of the Uterine Cervix
- 1 January 2001
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 48 (2) , 219-225
PTHrP and PTH/PTHrP Receptor Expressions in Human Endometrium.
We investigated menstrual cycle-dependent changes in the expression of PTHrP and PTH/PTHrP receptor in the human endometrium by immunohistochemistry, and competitive reverse transcription and polymerase chain reaction (RT-PCR). Human endometrial tissues were obtained from patients who underwent gynecological surgery due to cervical cancer (carcinoma in situ) or ovarian cancer. The mean age of the 20 patients was 36.5 (range 31-44) years. For analysis of mRNA expression, specimens from proliferative (mid, n=5; late, n=5) and secretory (early, n=4; mid, n=4) phases were used. Immunohistochemical expression of PTHrP and PTH/PTHrP receptor was observed in the cytoplasm of both epithelial and stromal cells. Stronger staining of PTHrP was found in glandular epithelial cells than in stromal cells. The staining during the proliferative phase was stronger than that in the secretory phase and the difference was particularly remarkable when comparing samples from the same patient. PTH/PTHrP receptor was also present in both epithelial and stromal cells of the endometrium. However, no difference was observed in receptor expression between the proliferative and secretory phases. Competitive RT-PCR revealed that the expression of PTHrP mRNA was higher during the proliferative phase than in the secretory phase, although no difference was observed in PTH/PTHrP receptor mRNA expression. The data suggest that endometrial proliferation may be mediated by a local PTHrP autocrine and/or paracrine mechanism.
- 1 January 2001
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 48 (2) , 219-225
PTHrP and PTH/PTHrP Receptor Expressions in Human Endometrium.
We investigated menstrual cycle-dependent changes in the expression of PTHrP and PTH/PTHrP receptor in the human endometrium by immunohistochemistry, and competitive reverse transcription and polymerase chain reaction (RT-PCR). Human endometrial tissues were obtained from patients who underwent gynecological surgery due to cervical cancer (carcinoma in situ) or ovarian cancer. The mean age of the 20 patients was 36.5 (range 31-44) years. For analysis of mRNA expression, specimens from proliferative (mid, n=5; late, n=5) and secretory (early, n=4; mid, n=4) phases were used. Immunohistochemical expression of PTHrP and PTH/PTHrP receptor was observed in the cytoplasm of both epithelial and stromal cells. Stronger staining of PTHrP was found in glandular epithelial cells than in stromal cells. The staining during the proliferative phase was stronger than that in the secretory phase and the difference was particularly remarkable when comparing samples from the same patient. PTH/PTHrP receptor was also present in both epithelial and stromal cells of the endometrium. However, no difference was observed in receptor expression between the proliferative and secretory phases. Competitive RT-PCR revealed that the expression of PTHrP mRNA was higher during the proliferative phase than in the secretory phase, although no difference was observed in PTH/PTHrP receptor mRNA expression. The data suggest that endometrial proliferation may be mediated by a local PTHrP autocrine and/or paracrine mechanism.
- Open Access
- 1 January 1970
- Published by Nepal Journals Online (JOL) in Nepal Journal of Obstetrics and Gynaecology
- Vol. 2 (2) , 86-88
Current and future in FHR monitoring
Doi:10.3126/njog.v2i2.1465 N. J. Obstet. Gynaecol 2007 Nov-Dec; 2 (2): 86 - 88
- 1 January 1970
- Published by Nepal Journals Online (JOL) in Nepal Journal of Obstetrics and Gynaecology
- Vol. 2 (2) , 86-88
Open AccessCurrent and future in FHR monitoring
Doi:10.3126/njog.v2i2.1465 N. J. Obstet. Gynaecol 2007 Nov-Dec; 2 (2): 86 - 88